Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
Abstract Background Serine hydroxymethyltransferase 2 (SHMT2) is a vital metabolic enzyme in one carbon metabolism catalyzing the conversion of serine to glycine, which has been reported to play a crucial role in the progression of tumors. However, its function in tongue squamous cell carcinoma (TSC...
Main Authors: | Yan Liao, Fang Wang, Yadong Zhang, Hongshi Cai, Fan Song, Jinsong Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-01880-5 |
Similar Items
-
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
by: Yongli Situ, et al.
Published: (2023-09-01) -
Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
by: Zhi-Zhong Wu, et al.
Published: (2020-10-01) -
Immune-Related Long Non-Coding RNA Signatures for Tongue Squamous Cell Carcinoma
by: Daniel Hu, et al.
Published: (2023-05-01) -
Genome-wide identification and expression analysis of serine hydroxymethyltransferase (SHMT) gene family in tomato (Solanum lycopersicum)
by: Zesheng Liu, et al.
Published: (2022-02-01) -
Significance of neo-angiogenesis and immuno-surveillance cells in squamous cell carcinoma of the tongue
by: Juma O. Alkhabuli
Published: (2007-02-01)